Cargando…
Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
Euglycemic diabetic ketoacidosis (euDKA) is an uncommon condition, which is characterized by an elevated anion gap metabolic acidosis with ketonemia/ketonuria, in the presence of normal blood glucose levels. Common risk factors for the development of this condition include pregnancy, prolonged fasti...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934848/ https://www.ncbi.nlm.nih.gov/pubmed/36819400 http://dx.doi.org/10.7759/cureus.33892 |
_version_ | 1784889955170910208 |
---|---|
author | Chauhan, Sukhjinder Manov, AndreyI Dhillon, Gundip S Shah, Pinak |
author_facet | Chauhan, Sukhjinder Manov, AndreyI Dhillon, Gundip S Shah, Pinak |
author_sort | Chauhan, Sukhjinder |
collection | PubMed |
description | Euglycemic diabetic ketoacidosis (euDKA) is an uncommon condition, which is characterized by an elevated anion gap metabolic acidosis with ketonemia/ketonuria, in the presence of normal blood glucose levels. Common risk factors for the development of this condition include pregnancy, prolonged fasting, acute pancreatitis, and bariatric surgery. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been identified as a rare cause of euDKA. A recent literature review on PubMed found only 86 case reports of euDKA secondary to SGLT inhibitors published in the medical literature up to December 2022. Here, we present the case of a 43-year-old man who was taking empagliflozin, an SGLT-2 inhibitor. The patient was found to have euDKA, which was likely an adverse effect of his medication. |
format | Online Article Text |
id | pubmed-9934848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-99348482023-02-17 Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus Chauhan, Sukhjinder Manov, AndreyI Dhillon, Gundip S Shah, Pinak Cureus Cardiology Euglycemic diabetic ketoacidosis (euDKA) is an uncommon condition, which is characterized by an elevated anion gap metabolic acidosis with ketonemia/ketonuria, in the presence of normal blood glucose levels. Common risk factors for the development of this condition include pregnancy, prolonged fasting, acute pancreatitis, and bariatric surgery. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been identified as a rare cause of euDKA. A recent literature review on PubMed found only 86 case reports of euDKA secondary to SGLT inhibitors published in the medical literature up to December 2022. Here, we present the case of a 43-year-old man who was taking empagliflozin, an SGLT-2 inhibitor. The patient was found to have euDKA, which was likely an adverse effect of his medication. Cureus 2023-01-17 /pmc/articles/PMC9934848/ /pubmed/36819400 http://dx.doi.org/10.7759/cureus.33892 Text en Copyright © 2023, Chauhan et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Chauhan, Sukhjinder Manov, AndreyI Dhillon, Gundip S Shah, Pinak Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus |
title | Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus |
title_full | Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus |
title_fullStr | Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus |
title_full_unstemmed | Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus |
title_short | Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus |
title_sort | empagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934848/ https://www.ncbi.nlm.nih.gov/pubmed/36819400 http://dx.doi.org/10.7759/cureus.33892 |
work_keys_str_mv | AT chauhansukhjinder empagliflozinassociatedeuglycemicdiabeticketoacidosisinapatientwithtype2diabetesmellitus AT manovandreyi empagliflozinassociatedeuglycemicdiabeticketoacidosisinapatientwithtype2diabetesmellitus AT dhillongundips empagliflozinassociatedeuglycemicdiabeticketoacidosisinapatientwithtype2diabetesmellitus AT shahpinak empagliflozinassociatedeuglycemicdiabeticketoacidosisinapatientwithtype2diabetesmellitus |